RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Amarillo, TX · Austin, TX · +137 more sites
Obesity clinical trials in El Paso, TX
7 recruiting obesity studies with a site in El Paso, TX.
RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
Austin, TX · Brownsville, TX · Dallas, TX · +77 more sites
RecruitingPhase 3NCT07684235
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Sponsor: Amgen
Austin, TX · Bellaire, TX · Dallas, TX · +68 more sites
RecruitingPhase 3NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Sponsor: AstraZeneca
DeSoto, TX · El Paso, TX · Houston, TX · +51 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Amarillo, TX · Austin, TX · Conroe, TX · +118 more sites
RecruitingPhase 2NCT06717698
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Sponsor: Novo Nordisk A/S
El Paso, TX · San Antonio, TX · +15 more sites
RecruitingNot applicableNCT03947697
Improving Glycemic Control With Electrical Stimulation
Sponsor: University of Texas, El Paso
El Paso, TX
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.